Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
Adverum Biotechnologies (ADVM) Stock Price & Analysis
404 Followers
ADVM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $1.82
Previous Close$0.8
Volume194.70K
Average Volume (3M)437.64K
Market Cap
$80.69M
Enterprise Value-$16.87M
Total Cash (Recent Filing)$203.26M
Total Debt (Recent Filing)$105.70M
Price to Earnings (P/E)-0.5
Beta0.61
Next Earnings
May 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.58
Shares Outstanding99,729,025
10 Day Avg. Volume814,751
30 Day Avg. Volume437,636
Standard Deviation0.26
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.36
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)242.90
P/FCF Ratio-0.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.11
Forecast
1Y Price Target
$2.00Price Target Upside150.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Adverum Biotechnologies News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADVM FAQ
What was Adverum Biotechnologies’s price range in the past 12 months?
Adverum Biotechnologies lowest stock price was $0.53 and its highest was $1.82 in the past 12 months.
What is Adverum Biotechnologies’s market cap?
Currently, no data Available
When is Adverum Biotechnologies’s upcoming earnings report date?
Adverum Biotechnologies’s upcoming earnings report date is May 10, 2023 which is in 42 days.
How were Adverum Biotechnologies’s earnings last quarter?
Currently, no data Available
Is Adverum Biotechnologies overvalued?
According to Wall Street analysts Adverum Biotechnologies’s price is currently Undervalued.
Does Adverum Biotechnologies pay dividends?
Adverum Biotechnologies does not currently pay dividends.
What is Adverum Biotechnologies’s EPS estimate?
Adverum Biotechnologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adverum Biotechnologies have?
Adverum Biotechnologies has 99,729,030 shares outstanding.
What happened to Adverum Biotechnologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Adverum Biotechnologies?
Among the largest hedge funds holding Adverum Biotechnologies’s share is Versant Venture Management, LLC. It holds Adverum Biotechnologies’s shares valued at 3M.
---
Adverum Biotechnologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (150.00% Upside)
$2.00 (150.00% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 4.4%
Last 30 Days ▼ 4.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.02%
12-Months-Change
Fundamentals
Return on Equity
-56.36%
Trailing 12-Months
Asset Growth
-32.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Adverum Biotechnologies
Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr. and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Menlo Park, CA.
---
Top 5 ETFs holding ADVM
iShares Core S&P Total U.S. Stock Market ETF
Dimensional US Core Equity Market ETF
Up to five ETFs with an Outperform Smart Score that hold ADVM. The ETFs are listed according to market value of ADVM within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---